Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Understanding this nuanced risk-benefit profile enables informed shared decision-making between healthcare providers and patients considering GLP-1 therapy
For a topical cosmetic, follow the exact product's directions and choose a time you can use it consistently
A: Yes, GHK-Cu is generally well tolerated, even with those with sensitive skin
By definition, they are unapproved drugs
Sources: Teichman et al., JCEM 2006 | Raun et al., Eur J Endocrinol 1998 | Alba et al., Am J Physiol 2006 Security Profile & Chemical Identity Molecular specifications of the two peptides and documented hormonal selectivity Chemical Identity Pre-formulated Mix Two complementary peptides targeting distinct receptors for synergistic GH stimulation Documented Hormonal Selectivity Profile verified in human clinical trials Key benefit of this combination Published Clinical Data Key studies on each component and the synergy of GHRH + GHRP 2-10x Dose-dependent increase in plasma GH (30-60 g/kg SC) Results CJC-1295 (days 28 and 49) Selective First GH secretagogue without raising cortisol, prolactin or ACTH levels Selectivity vs
US$ 28.67
US$ 25.23
US$ 25.78
